​

Funding Round

Series A - Cour Pharmaceuticals Development

Series A - Cour Pharmaceuticals Development

Investment Firm

Overview

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Announced Date

Jan 30, 2024

Closed on Date

Jan 30, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Alpha Wave Ventures

Alpha Wave Ventures

Alpha Wave Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorAlpha Wave Ventures
Participant InvestorAngelini Ventures
Participant InvestorJDRF T1D Fund
Participant InvestorBristol-Myers Squibb
Participant InvestorRoche Venture Fund

Round Details and Background

Cour Pharmaceuticals Development raised $105000000 on 2024-01-30 in Series A

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 07, 2022
Venture Round - Cour Pharmaceuticals Development
2-30.0M
Jan 30, 2024
Series A - Cour Pharmaceuticals Development
7-105.0M
Aug 28, 2014
Debt Financing - Cour Pharmaceuticals Development
-500.0K
Apr 23, 2013
Seed Round - Cour Pharmaceuticals Development
-17.0K

Recent Activity

There is no recent news or activity for this profile.